Natural Sciences
Life Sciences
Scientific Computing
Scientific Computing

Hilde Langseth, Cancer Registry of Norway, Institute of Population - based Cancer Research, Oslo, Norway

Marsilius Arkaden, Turm Süd, K13, Im Neuenheimer Feld 130.2

Heidelberger Kolloquium Medizinische Biometrie, Informatik und Epidemiologie

The Janus Serum Bank of Norway is a large population-based biobank with pre-diagnostic serum samples from 318 628 Norwegians. Samples can be used for cancer research only. The biobank, managed by the Cancer Registry of Norway, is linked annually to the registry for incidence and follow-up of cancer patients. At present, the number of incident cancer cases in the Janus cohort is 69 745, counting 30 502 in female donors and 39 243 in male donors. The most common cancers are prostate cancer in men and breast cancer in women, constituting 28.4% and 27.4% of the cancer burden in the cohort, respectively. The Janus Serum Bank Cohort can be used, for example, to address research questions on the latent period or preclinical stage before the tumour has developed and is ideal for the search of novel biomarkers potentially relevant to cancer aetiology, early diagnosis, prognosis and choice of therapy. Research groups are welcome to apply for access to serums samples and data at Additional details on the cohort set up, participants, follow-up, measurements, key findings and publications will be discussed in the talk.

Event data:
Import event data into Outlook Calendar